Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 88

Sort by

Sort Order Select

Journal Articles

Novel Promising Therapeutic Strategies for Advancing the Treatment of KMT2A -Rearranged AML

Ambra Da Ros, Alberto Peloso, Giorgia Longo, Maddalena Benetton, Valentina Indio, Stefano Cairo, Monica Sandri, Barbara Buldini, Silvia Bresolin, Antonio Rosato, Andrea Pession, Claudia Tregnago, Franco Locatelli, Martina Pigazzi

Blood (2024) 144 (Supplement 1): 2910.

https://doi.org/10.1182/blood-2024-200132

Published: 2024

Journal Articles

Final Results of the AIEOP (Associazione Italiana Ematologia/Oncologia Pediatrica) AML 2013 Prospective Randomized Trial in Childhood Acute Myeloid Leukemia (AML)

Franco Locatelli, Barbara Buldini, Martina Pigazzi, Carmelo Rizzari, Rosanna Cuccurullo, Franca Fagioli, Manuela Tumino, Luca Lo Nigro, Maria Giuseppina Cefalo, Luisa Strocchio, Marco Zecca, Marco Becilli, Andrea Pession, Nicola Santoro, Concetta Micalizzi, Riccardo Masetti, Pietro Merli

Blood (2023) 142 (Supplement 1): 728.

https://doi.org/10.1182/blood-2023-188682

Published: 2023

Journal Articles

Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children

Blood (2023) 142 (16): 1387–1398.

https://doi.org/10.1182/blood.2023020026

Published: 2023

Includes: Supplemental data

Journal Articles

Lentiviral-Mediated Gene Therapy for the Treatment of Adenosine Deaminase 2 Deficiency

Alessandra Mortellaro, Matteo Zoccolillo, Cristina Mesa Nuñez, Alessia Brix, Immacolata Brigida, Federica Barzaghi, Serena Scala, Raisa Jofra Hernández, Luca Basso-Ricci, Mariasilvia Colantuoni, Simone Cesaro, Francesca Conti, Andrea Pession, Fabio Benedetti, Marco Gattorno, Luigi Naldini, Maria Pia Cicalese, Anna Pistocchi, Alessandro Aiuti

Blood (2021) 138 (Supplement 1): 2937.

https://doi.org/10.1182/blood-2021-152127

Published: 2021

Journal Articles

Role of Mir-192-5p during Response to Azacitidine and Lenalidomide Therapy in Myelodysplastic Syndromes

Matilde Y Follo, Alessia De Stefano, Sara Mongiorgi, Valentina Indio, Annalisa Astolfi, Stefano Ratti, Andrea Pellagatti, Miriam Fogli, Andrea Pession, Michele Cavo, Lucia Manzoli, Lucio Cocco, Jacqueline Boultwood, Sarah Parisi, Stefania Paolini, Carlo Finelli

Blood (2021) 138 (Supplement 1): 3673.

https://doi.org/10.1182/blood-2021-149183

Published: 2021

Journal Articles

Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion

Annalisa Astolfi, Riccardo Masetti, Valentina Indio, Salvatore Nicola Bertuccio, Daria Messelodi, Simone Rampelli, Davide Leardini, Matteo Carella, Salvatore Serravalle, Virginia Libri, Jessica Bandini, Stefano Volinia, Marco Candela, Andrea Pession

Blood (2021) 138 (18): 1773–1777.

https://doi.org/10.1182/blood.2021011677

Published: 2021

Includes: Supplemental data

Journal Articles

Sequential Analysis of miRNA Profiling during Azacitidine and Lenalidomide Therapy in Myelodysplastic Syndromes

Matilde Y Follo, PhD, Sara Mongiorgi, PhD, Alessia De Stefano, BSc, Valentina Indio, PhD, Annalisa Astolfi, PhD, Andrea Pellagatti, Stefano Ratti, MD, Miriam Fogli, PhD, Sarah Parisi, MDPhD, Andrea Pession, Michele Cavo, Lucia Manzoli, MD, Lucio Cocco, MD, Jacqueline Boultwood, Carlo Finelli

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-136942

Published: 2020

Journal Articles

Incidence and Therapeutic Implications of Germline TP53 Mutations in Hypodiploid Childhood Acute Lymphoblastic Leukemia: A Retrospective Analysis of the Italian Cohort

Laura Rachele Bettini, Claudia Saitta, Barbara Buldini, Geertruij Te Kronnie, Stefano Rebellato, Daniela Silvestri, Elena Barisone, Andrea Pession, Marco Rabusin, Concetta Micalizzi, Franco Locatelli, MD PhD, Carmelo Rizzari, Maria Grazia Valsecchi, PhD, Andrea Biondi, MD, Grazia Fazio, Giovanni Cazzaniga, PhD

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-142729

Published: 2020

Journal Articles

Negative Prognostic Relevance of a Specific 3-Gene Cluster in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Blood (2018) 132 (Supplement 1): 4347.

https://doi.org/10.1182/blood-2018-99-112062

Published: 2018

Journal Articles

Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL

Anna Maria Testi, Andrea Pession, Daniela Diverio, David Grimwade, Brenda Gibson, Amilcar Cardoso de Azevedo, Lorena Moran, Guy Leverger, Sarah Elitzur, Henrik Hasle, Jutte van der Werff ten Bosch, Owen Smith, Marisa De Rosa, Alfonso Piciocchi, Francesco Lo Coco, Robin Foà, Franco Locatelli, Gertjan J. L. Kaspers

Blood (2018) 132 (4): 405–412.

https://doi.org/10.1182/blood-2018-03-836528

Published: 2018

Includes: Supplemental data

Journal Articles

The ETO2-GLIS2 Fusion Oncogene Alters Early Human Hematopoiesis in an Induced Pluripotent Stem Cells-Derived Model of Pediatric Acute Megakaryoblastic Leukemia

Salvatore Nicola Bertuccio, Marie Cambot, Cécile K Lopez, Larissa Lordier, Alessandro Donada, Zakia Aid, Franco Locatelli, MD PhD, Riccardo Masetti, MDPhD, William Vainchenker, MD PhD, Hana Raslova, PhD, Andrea Pession, MD, Thomas Mercher, PhD

Blood (2017) 130 (Supplement 1): 2512.

https://doi.org/10.1182/blood.V130.Suppl_1.2512.2512

Published: 2017

Journal Articles

Preliminary Results of Gau-PED Study: Prevalence of Gaucher Disease in Paediatric Patients Selected By an Appropriate Diagnostic Algorithm

William Morello, MD, Mirella Filocamo, Marina Stroppiano, Maja Di Rocco, MD, Nicola Tovaglieri, MD, Giovanna Russo, MD, Francesca Furlan, MD, Roberta Burnelli, MD, Andrea Pession, MD

Blood (2017) 130 (Supplement 1): 1187.

https://doi.org/10.1182/blood.V130.Suppl_1.1187.1187

Published: 2017

Journal Articles

Rhob Overexpression Boosts Relapse of t(8;21) RUNX1-RUNX1T1 Rearranged Acute Myeloid Leukemia.

Pigazzi Martina, PhD, Zampini Matteo, PhD, Claudia Tregnago, PhD, Valeria Bisio, PhD, Luca Simula, PhD, Giulia Borella, PhDstudent, Carlo Zanon, PhD, Valentina Serafin, PhD, Benedetta Accordi, PhD, Silvia Campello, PhD, Barbara Buldini, MD PhD, Andrea Pession, MD, Franco Locatelli, MD PhD, Giuseppe Basso, MD

Blood (2017) 130 (Supplement 1): 1192.

https://doi.org/10.1182/blood.V130.Suppl_1.1192.1192

Published: 2017

Journal Articles

Long Non Coding RNA BALR2-CDK6 Axis Influences Cell Differentiation and Metabolic Status of Acute Myeloid Leukemia

Valeria Bisio, PhD, Claudia Tregnago, PhD, Matteo Zampini, PhD, Giulia Borella, PhDstudent, Thilini Fernando, Dinesh S. Rao, MD PhD, Andrea Pession, MD, Franco Locatelli, MD PhD, Giuseppe Basso, MD, Pigazzi Martina, PhD

Blood (2017) 130 (Supplement 1): 3935.

https://doi.org/10.1182/blood.V130.Suppl_1.3935.3935

Published: 2017

Journal Articles

Gene Mutations and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Matilde Y Follo, PhD, Andrea Pellagatti, PhD, Richard N Armstrong, PhD, Stefano Ratti, MD, Sara Mongiorgi, PhD, Annalisa Astolfi, PhD, Valentina Indio, PhD, Cristina Clissa, MD PhD, Domenico Russo, MD, Marco Gobbi, MD, Marilena Barraco, PhD, Sarah Parisi, MD PhD, Andrea Pession, MD, Michele Cavo, MD, Lucia Manzoli, MD, Lucio Cocco, MD, Jacqueline Boultwood, PhD, Carlo Finelli, MD

Blood (2017) 130 (Supplement 1): 5299.

https://doi.org/10.1182/blood.V130.Suppl_1.5299.5299

Published: 2017

Journal Articles

Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL

Blood (2017) 130 (19): 2146–2149.

https://doi.org/10.1182/blood-2017-05-782086

Published: 2017

Includes: Supplemental data

Journal Articles

Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin

Franco Locatelli, MD, Maria Ester Bernardo, MD, Alice Bertaina, MD PhD, Carla Rognoni, PhD, Patrizia Comoli, MD, Attilio Rovelli, MD, Andrea Pession, MD PhD, Franca Fagioli, MD, Claudio Favre, MD, Edoardo Lanino, MD, Giovanna Giorgiani, MD, Pietro Merli, MD, Arcangelo Prete, MD, Marco Zecca, MD

Blood (2016) 128 (22): 1168.

https://doi.org/10.1182/blood.V128.22.1168.1168

Published: 2016

Journal Articles

Role of Nuclear Inositide Signalling and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Matilde Follo, PhD, Sara Mongiorgi, PhD, Cristina Clissa, MD, Annalisa Astolfi, PhD, Domenico Russo, MD, Marco Gobbi, MD, Costanza Bosi, MD, Monica Crugnola, MD, Marta Stanzani, MD, Stefano Ratti, MD, Sarah Parisi, MD, Marilena Barraco, PhD, Lucia Manzoli, MD, Andrea Pession, MD, Lucio Cocco, MD, PhD, Carlo Finelli, MD

Blood (2016) 128 (22): 5091.

https://doi.org/10.1182/blood.V128.22.5091.5091

Published: 2016

Journal Articles

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Anna Maria Testi, MD, Andrea Pession, MD, David Grimwade, PhD FRCPath, Daniela Diverio, PhD, Christine Ragu, PhD, Sarah Elitzur, MD, Alcira Fynn, MD, Henrik Hasle, MD PhD, Jutte Van der Werff ten Bosch, MD PhD, Owen Smith, MD, Brenda Gibson, MD, Franco Locatelli, MD PhD, Gertjan J.L. Kaspers, MD PhD

Blood (2015) 126 (23): 563.

https://doi.org/10.1182/blood.V126.23.563.563

Published: 2015

Journal Articles

Outcome of Early T-Cell Precursor Acute Lymphoblastic Leukemia in AIEOP Patients Treated with the AIEOP-BFM ALL 2000 Study

Blood (2014) 124 (21): 3780.

https://doi.org/10.1182/blood.V124.21.3780.3780

Published: 2014

NARROW

Novel Promising Therapeutic Strategies for Advancing the Treatment of KMT2A -Rearranged AML

Final Results of the AIEOP (Associazione Italiana Ematologia/Oncologia Pediatrica) AML 2013 Prospective Randomized Trial in Childhood Acute Myeloid Leukemia (AML)

Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children

Lentiviral-Mediated Gene Therapy for the Treatment of Adenosine Deaminase 2 Deficiency

Role of Mir-192-5p during Response to Azacitidine and Lenalidomide Therapy in Myelodysplastic Syndromes

Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion

Sequential Analysis of miRNA Profiling during Azacitidine and Lenalidomide Therapy in Myelodysplastic Syndromes

Incidence and Therapeutic Implications of Germline TP53 Mutations in Hypodiploid Childhood Acute Lymphoblastic Leukemia: A Retrospective Analysis of the Italian Cohort

Negative Prognostic Relevance of a Specific 3-Gene Cluster in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL

The ETO2-GLIS2 Fusion Oncogene Alters Early Human Hematopoiesis in an Induced Pluripotent Stem Cells-Derived Model of Pediatric Acute Megakaryoblastic Leukemia

Preliminary Results of Gau-PED Study: Prevalence of Gaucher Disease in Paediatric Patients Selected By an Appropriate Diagnostic Algorithm

Rhob Overexpression Boosts Relapse of t(8;21) RUNX1-RUNX1T1 Rearranged Acute Myeloid Leukemia.

Long Non Coding RNA BALR2-CDK6 Axis Influences Cell Differentiation and Metabolic Status of Acute Myeloid Leukemia

Gene Mutations and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL

Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin

Role of Nuclear Inositide Signalling and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Outcome of Early T-Cell Precursor Acute Lymphoblastic Leukemia in AIEOP Patients Treated with the AIEOP-BFM ALL 2000 Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only